Advanced search
Start date

Synthesis of biologically active phenols and derivatives

Grant number: 11/50435-8
Support Opportunities:Regular Research Grants
Duration: June 01, 2011 - February 28, 2014
Field of knowledge:Physical Sciences and Mathematics - Chemistry - Organic Chemistry
Principal Investigator:José Agustín Pablo Quincoces Suárez
Grantee:José Agustín Pablo Quincoces Suárez
Host Institution: Pró-Reitoria Acadêmica. Universidade Bandeirantes (UNIBAN). São Paulo , SP, Brazil


This research project is based on the biological results obtained under financial support from FAPESP, project-number: 2001/03756-1 e 2004/11351-0, exhibited by polifunctional phenols and its derivatives. The compound, sodium 4-[5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl]-2-methoxy-phenolate, DM1 exhibited marked action as a potent antitumor agent against melanoma and breast cancer. Also, this compound exhibited an excellent activity as powerful adjuvant agent for a higher antitumor activity of conventional chemotherapeutic drugs, as a potent antimethastatic and antimutagenic, protecting and stimulating bone marrow. For this reason, we planned with DM1: a) In vivo analgesic assay in rats. We planned the synthesis of new substituted acetophenone and derivatives starting from 2-hydroxy-5-(2-methylbut-2-enyl)acetophenone used as stardard antitumor reference. Therefore we planned the synthesis of 1,4-pentadien-3-ones, starting from iodated polifunctional phenols and aromatic 1-alkyne or with alkyl acrylate, respectivelly, in the presence of different Pd-catalysts. All the compounds will be purified and their structures shall be characterized by spectroscopic methods and organic elemental quantitative analysis.Finally, antitumor, antioxidant, analgesic and anti-inflammatory properties will be determined and the impact of the in vitro treatment with synthesized componds, on epigenetic regulation of immune system cells, besides looking for markers of differential metilation on DNA, after the employment of these compounds. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications (4)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
PAULINO, NIRALDO; PAULINO, AMARILIS SCREMIN; DINIZ, SUSANA N.; DE MENDONCA, SERGIO; GONCALVES, IVAIR D.; FLORES, FERNANDA FAIAO; SANTOS, REGINALDO PEREIRA; RODRIGUES, CARINA; PARDI, PAULO CELSO; QUINCOCES SUAREZ, JOSE AGUSTIN. Evaluation of the anti-inflammatory action of curcumin analog (DM1): Effect on iNOS and COX-2 gene expression and autophagy pathways. Bioorganic & Medicinal Chemistry, v. 24, n. 8, p. 1927-1935, . (11/50435-8)
FAIAO-FLORES, FERNANDA; QUINCOCES SUAREZ, JOSE AGUSTIN; MARIA-ENGLER, SILVYA STUCHI; SOTO-CERRATO, VANESSA; PEREZ-TOMAS, RICARDO; MARIA, DURVANEI AUGUSTO. The curcumin analog DM-1 induces apoptotic cell death in melanoma. TUMOR BIOLOGY, v. 34, n. 2, p. 1119-1129, . (08/58817-4, 11/50435-8)
FAIAO-FLORES, FERNANDA; QUINCOCES SUAREZ, JOSE AGUSTIN; SOTO-CERRATO, VANESSA; ESPONA-FIEDLER, MARGARITA; PEREZ-TOMAS, RICARDO; MARIA, DURVANEI AUGUSTO. Bcl-2 family proteins and cytoskeleton changes involved in DM-1 cytotoxic effect on melanoma cells. TUMOR BIOLOGY, v. 34, n. 2, p. 1235-1243, . (11/50435-8)
FAIAO-FLORES, FERNANDA; QUINCOCES SUAREZ, JOSE AGUSTIN; FRUET, ANDREA COSTA; MARIA-ENGLER, SILVYA STUCHI; PARDI, PAULO CELSO; MARIA, DURVANEI AUGUSTO. Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression. PLoS One, v. 10, n. 3, . (11/50435-8)

Please report errors in scientific publications list using this form.